My watch list
my.bionity.com  
Login  

206 Current news from israel

rss
matching the following criteria

CMC Biologics and OncoSynergy Enter into an Agreement for Accelerated Process Development of an Investigational Drug to Combat Ebola

Experimental monoclonal antibody to be used in clinical trials with patients in West Africa infected with the Ebola virus

18-12-2014

CMC Biologics and OncoSynergy have entered into an agreement for process development and GMP manufacture of OS2966 – a novel potential treatment for Ebola. The investigational drug candidate, designed to inhibit a major cellular adhesion receptor (CD29) that is fundamental for progression of ...

more

image description
Fat cells reprogrammed to increase fat burning

16-12-2014

White adipose tissue stores excess calories as fat that can be released for use in other organs during fasting. Mammals also have small amounts of brown adipose tissue, which primarily acts as an effective fat burner for the production of heat. Now researchers from the University of Southern ...

more

Genmab Announces Phase II Study of Daratumumab in Non-Hodgkin’s Lymphomas

05-12-2014

Genmab A/S announced that its collaboration partner, Janssen Biotech, Inc. (Janssen) plans to start a Phase II study of daratumumab in non-Hodgkin’s lymphomas (NHL). The study (LYM2001) will evaluate daratumumab monotherapy in three different types of NHL, diffuse large B-cell lymphoma (DLBCL), ...

more

New enzyme technology converts waste oils into biodiesel

04-12-2014

Novozymes announced the launch of Novozymes Eversa®, the first commercially available enzymatic solution to make biodiesel from waste oils. The enzymatic process converts used cooking oil or other lower grade oils into biodiesel. Biodiesel producers can thereby reduce their raw material costs. ...

more

Contera Pharma announces acquisition by Korean Bukwang Pharmaceutical

JM-010 to enter global development for L-DOPA induced dyskinesia

03-12-2014

Contera Pharma announced that Bukwang Pharmaceutical has acquired 100% of Contera Pharma from its current shareholders. The shareholders received an undisclosed upfront payment and are entitled to future contingent and royalty payments. Contera Pharma was founded by John Bondo Hansen and Mikael ...

more

New guide to the genetic jungle of muscles can help health research

28-11-2014

New guide to the genetic jungle of muscles can help health research Researchers from Aarhus University and Bispebjerg Hospital have created a comprehensive overview of how tens of thousands of genes interact in relation to the behavior of muscles. At the same time, they have developed a guide to ...

more

Genmab Announces New Phase III Combination Study of Daratumumab in Frontline Multiple Myeloma

12-11-2014

Genmab A/S announced that the French Intergroup of Myeloma (IFM) in collaboration with Dutch-Belgian Cooperative Trial Group for Hematology Oncology (HOVON) and Janssen Biotech, Inc. (Janssen) plans to start an additional Phase III study of daratumumab in frontline multiple myeloma. The study ...

more

Genmab Reaches USD 10 Million Milestone in Daratumumab Collaboration with Janssen

Milestone triggered by progress in the Phase III study of daratumumab in combination with bortezomib and dexamethasone

28-10-2014

Genmab A/S announced it has reached the fourth milestone in its daratumumab collaboration with Janssen Biotech, Inc.. The USD 10 million milestone payment was triggered by progress in the ongoing Phase III study (“CASTOR” MMY3004) of daratumumab in combination with bortezomib and dexamethasone ...

more

Researchers debunk myth about Parkinson's disease

17-09-2014

Using advanced computer models, neuroscience researchers at the University of Copenhagen have gained new knowledge about the complex processes that cause Parkinson's disease. The findings have recently been published in the Journal of Neuroscience. The defining symptoms of Parkinson's disease are ...

more

Scientists disagree on responsible research

10-04-2014

Responsible research has been put firmly on the political agenda with, for instance, EU's Horizon 2020 programme in which all research projects must show how they contribute responsibly to society. New research from the University of Copenhagen reveals that the scientists themselves place great ...

more

Page 1 From 21
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE